10x Genomics, Inc. · NASDAQ:TXG
Saxonov Serge sold 25,000 10x Genomics, Inc. shares (Form 4)
Traded Sep 22, 2026 · Filed Sep 24, 2026
On Sep 22, 2026, Saxonov Serge (Director, Chief Executive Officer) sold 25,000 10x Genomics, Inc. shares at an average US$81.22 for US$2.03M under a trading plan, leaving 1,050,249 shares. Filed Sep 24, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$81.22 average (US$78.23 to US$82.37)
- Value
- US$2.03M
- Holding after
- 1,050,249 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Class A Common Stock | Sale | 1,000 | US$78.23 | 1,074,249 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 2,000 | US$79.62 | 1,072,249 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 9,300 | US$80.90 | 1,062,949 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 9,900 | US$81.83 | 1,053,049 | Direct |
| Sep 22, 2026 | Class A Common Stock | Sale | 2,800 | US$82.37 | 1,050,249 | Direct |
Source
Related
- 10x Genomics, Inc.
- Saxonov Serge
- 10x Genomics, Inc. shareholders
- Form 4 · Saxonov Serge · Sep 3, 2026
- Form 4 · Saxonov Serge · Aug 28, 2026
- Form 4 · Saxonov Serge · Aug 26, 2026
- Form 4 · Saxonov Serge · Aug 24, 2026
- Form 4 · Saxonov Serge · Jun 24, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026